The Koch Institute for Integrative Cancer Research at MIT

an accordion of endothelial cells stained in pink and green

Using MIT ingenuity to create knowledge, tools, and treatments to fight cancer

Join us 

Our Research Areas

From fundamental discoveries to engineering advances, we strategically pursue five areas of research that, across tumor types, are critical for rapid progress toward defeating cancer.

As a National Cancer Institute-designated basic cancer research center, we produce knowledge and tools to fight one of humanity's most persistent challenges.

NCI Cancer Center: A Cancer Center Designated by the National Cancer Institute
Detection & monitoring  
Metastasis  
Immunology & immunotherapy  
Nano-based drugs  
Precision medicine  

News

Angela Belcher and Paula Hammond win 2024 National Medals of Science, Technology

MIT News

January 3, 2025

Congratulations to MIT's latest National Medals of Science and Technology laureates, including the Koch Institute's own Angela Belcher and Paula Hammond!

Belcher was honored for her work designing novel materials for applications that include solar cells, batteries, and medical imaging, while Hammond was honored for developing methods for assembling thin films that can be used for drug delivery, wound healing, and many other applications.

Artifacts from a half century of cancer research

MIT Koch Institute

The Koch Institute celebrated the opening of a new exhibition celebrating in the half century of discoveries and advancements that have positioned MIT at the forefront of the fight against cancer.  

ROS-y outlook for novel immune approach

MIT Koch Institute

A new therapeutic approach from the Wittrup lab uses reactive oxygen species-induced cancer cell death to help jumpstart anti-tumor immune responses and synergize with existing immunotherapies for improved treatment of many solid tumor types.

More News 

At the Koch Institute for Integrative Cancer Research, scientists and engineers work together to solve some of the most difficult problems in cancer. We ask big questions in strategic areas, where the answers have big impacts on how we understand and treat cancer.